Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer's disease
about
sameAs
Shear stress modulation of IL-1β-induced E-selectin expression in human endothelial cellsUsing animal models to determine the significance of complement activation in Alzheimer's diseaseInhibition of microglial inflammatory responses by norepinephrine: effects on nitric oxide and interleukin-1beta productionInflammatory cytokine levels correlate with amyloid load in transgenic mouse models of Alzheimer's diseaseMicroglial cell dysregulation in brain aging and neurodegenerationAPOE-modulated Aβ-induced neuroinflammation in Alzheimer's disease: current landscape, novel data, and future perspectivemiR-155 is involved in Alzheimer's disease by regulating T lymphocyte functionInterleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathwayMicroglial Function across the Spectrum of Age and GenderEffects of (-)Epicatechin on the Pathology of APP/PS1 Transgenic MiceLow energy laser light (632.8 nm) suppresses amyloid-β peptide-induced oxidative and inflammatory responses in astrocytes.Brain abscess: Current management.Interleukin-1 mediates Alzheimer and Lewy body pathologies.Volume of the hippocampal subfields in healthy adults: differential associations with age and a pro-inflammatory genetic variant.Cerebrospinal fluid markers of neuroinflammation in delirium: a role for interleukin-1β in delirium after hip fractureInterleukin-1 receptor 1 knockout has no effect on amyloid deposition in Tg2576 mice and does not alter efficacy following Abeta immunotherapy.Secretory PLA2-IIA: a new inflammatory factor for Alzheimer's disease.Reversible demyelination, blood-brain barrier breakdown, and pronounced neutrophil recruitment induced by chronic IL-1 expression in the brain.Inflammation in central nervous system injuryWIN 55,212-2, agonist of cannabinoid receptors, prevents amyloid β1-42 effects on astrocytes in primary culture.C/T conversion alters interleukin-1A promoter function in a human astrocyte cell line.Neuroinflammatory Cytokines-The Common Thread in Alzheimer's PathogenesisTrisomy 21 and the brainInterleukin-1β Promoter Polymorphism Enhances the Risk of Sleep Disturbance in Alzheimer's DiseaseToll-like receptor (TLR) and inflammasome actions in the central nervous systemIncreased pro-inflammatory cytokines, glial activation and oxidative stress in the hippocampus after short-term bilateral adrenalectomyExtensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray studyLow-level laser therapy for beta amyloid toxicity in rat hippocampus.Interleukin 18 gene polymorphisms predict risk and outcome of Alzheimer's disease.Disruption of Fractalkine Signaling Leads to Microglial Activation and Neuronal Damage in the Diabetic Retina.Toll-like receptors in central nervous system glial inflammation and homeostasis.Exercise alters the immune profile in Tg2576 Alzheimer mice toward a response coincident with improved cognitive performance and decreased amyloidS. aureus-dependent microglial activation is selectively attenuated by the cyclopentenone prostaglandin 15-deoxy-Delta12,14- prostaglandin J2 (15d-PGJ2)Modulation of connexin expression and gap junction communication in astrocytes by the gram-positive bacterium S. aureus.Role of the Transforming-Growth-Factor-β1 Gene in Late-Onset Alzheimer's Disease: Implications for the TreatmentRole of neuroinflammation in adult neurogenesis and Alzheimer disease: therapeutic approachesAcute and subacute IL-1β administrations differentially modulate neuroimmune and neurotrophic systems: possible implications for neuroprotection and neurodegenerationGlial connexins and gap junctions in CNS inflammation and disease.Down's syndrome, neuroinflammation, and Alzheimer neuropathogenesis.Studies on brain volume, Alzheimer-related proteins and cytokines in mice with chronic overexpression of IL-1 receptor antagonist
P2860
Q21134771-198BE764-C69A-4904-9DDD-CCF69C64FD6CQ24796236-CBB9FA0A-09BC-4144-A510-F01064847035Q24796356-AF41822A-C321-4629-A823-E56ECBC158FCQ24803797-C3A09B31-DF14-4FD4-A878-1816B8CFAA1CQ26800212-5C898289-D5A9-4216-A7C7-A31D236DCDB2Q28085213-E641E3F5-2C2E-4A48-9BEC-5A98B8C69B70Q28087564-B1BB3ACC-8F06-43B0-A2F1-09F682EEA46DQ28571359-B4DBF4DA-919E-4EA5-836A-C37908D74C1DQ30235380-5F8CFFB0-BE64-44C6-94A5-78B0EFB8DCE4Q33620260-AD9A5EA6-B023-499E-B217-23535E58C7CCQ33706803-2E178945-3FEF-414C-827B-DEE7FC304B1EQ34381475-1AB04ACB-74F3-40AE-933D-DCF28A0C332FQ34537594-D2615D4B-AF72-4C14-AA95-A2AFA95D233DQ34747395-D42A447C-576B-4E8F-A2DB-56EA45FE854AQ34760173-508FFE01-4F75-40A8-8492-9389147FFC31Q35015949-0ECFC586-40C0-4883-ADD9-B41447809158Q35094556-C4E0DE0E-29B9-4830-9530-F801593ACD88Q35103371-EDD41C7E-F20F-472F-B006-0DE38CF6634EQ35213716-E2E38502-19B8-43CE-AE85-1B54EECDC6C0Q35601542-8491D0E4-E657-4780-B203-DE71BC0BC992Q35748268-FEDDF2B0-C8D4-4BC8-9A50-0E8285B3B505Q35815212-0B70F879-BCC9-422F-AE82-BE9D64C7E3E5Q35854503-7AD8494D-363E-4114-A0C5-26D20325937BQ35944099-B135E012-73E2-46E8-971B-5AFA50A1314FQ36058919-43DB0027-A0CF-4187-B274-032967519B25Q36120646-ABCC9863-5629-419B-9DC2-423469FE3F3BQ36164195-1FE7DAB1-FF4F-407F-AFB4-76E406689E35Q36183441-D884170B-B8C6-4814-8B31-8B0CD275AAAAQ36227141-3A7C873F-2317-453F-945E-75B353370233Q36271043-AE91BAAA-5A9C-4BA0-A1D0-6C1B01B705AFQ36422953-5C3FD07B-1712-43CF-8A70-7276E70A9D23Q36579182-0988ADBE-7D14-4827-BFA8-38BC346BCB54Q36631061-0A6BE9BE-612A-4B01-8E0A-7FAC7D7A907CQ36737299-43E44C41-EAD5-431C-80B6-9B9F66A21C36Q36798886-CEDCE81E-B44F-4B26-8951-FCD99C112F99Q36830938-47358F92-415C-471F-9BBC-CC8D4EB93FF5Q36851799-6A0664BA-E331-447E-8407-C5BB3B411651Q37111630-E32DB8BD-F977-4C4A-90B2-939F26E8D6BBQ37113208-E6EFFD23-A969-4A91-8DD0-53CD095CAC56Q37295661-8ED910F3-7F4F-4F4A-ACA5-65A1034A7CD1
P2860
Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer's disease
description
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2002
@ast
im August 2002 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: August 2002)
@en
vedecký článok (publikovaný 2002-08)
@sk
vědecký článek publikovaný v roce 2002
@cs
wetenschappelijk artikel (gepubliceerd in 2002-08)
@nl
наукова стаття, опублікована в серпні 2002
@uk
مقالة علمية (نشرت في أغسطس 2002)
@ar
name
Interleukin-1 in the genesis a ...... eration in Alzheimer's disease
@ast
Interleukin-1 in the genesis a ...... eration in Alzheimer's disease
@en
Interleukin-1 in the genesis a ...... eration in Alzheimer's disease
@nl
type
label
Interleukin-1 in the genesis a ...... eration in Alzheimer's disease
@ast
Interleukin-1 in the genesis a ...... eration in Alzheimer's disease
@en
Interleukin-1 in the genesis a ...... eration in Alzheimer's disease
@nl
prefLabel
Interleukin-1 in the genesis a ...... eration in Alzheimer's disease
@ast
Interleukin-1 in the genesis a ...... eration in Alzheimer's disease
@en
Interleukin-1 in the genesis a ...... eration in Alzheimer's disease
@nl
P2860
P3181
P1476
Interleukin-1 in the genesis a ...... eration in Alzheimer's disease
@en
P2093
Robert E Mrak
W Sue T Griffin
P2860
P304
P3181
P407
P577
2002-08-01T00:00:00Z